MedTrace Logo

Bisoprolol Plasma Residual Concentrations in Chronic Heart Failure

NCT03644446 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2018-08-23

No results posted yet for this study

Summary

This study evaluate the dosage of bisoprolol plasma residual concentrations in chronic heart failure with mild to reduced ejection fraction adult patients by dose and renal function.

Conditions

  • Heart Failure With Reduced Ejection Fraction

Interventions

BIOLOGICAL

Bisoprolol plasma residual concentration dosage

Bisoprolol plasma residual concentration dosage will be subsequently studied by renal function (altered if creatinine clearance \< 30mL/min, mild altered between 30-60mL/min, normal \> 60mL/min as estimated by the CKD-EPI formula)

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-02
Primary Completion
2019-11-02
Completion
2020-11-02

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03644446 on ClinicalTrials.gov